Literature DB >> 28425160

Causes of nephrotic syndrome and nephrotic-range proteinuria are different in adult Chinese patients: A single centre study over 33 years.

Jack Kit-Chung Ng1, Terry King-Wing Ma1, Fernand Mac-Moune Lai2, Kai Ming Chow1, Bonnie Ching-Ha Kwan1, Chi Bon Leung1, Philip Kam-To Li1, Cheuk Chun Szeto1.   

Abstract

AIM: The reported causes of nephrotic syndrome (NS) varies between different countries. Less is known about the causes of nephrotic-range proteinuria (NPU). We aimed to evaluate the underlying causes of NS and NPU.
METHODS: This was a single-centre, retrospective study of adult patients who underwent renal biopsy between 1983 and 2015 in a tertiary referral hospital in Hong Kong. We determined the distribution of histopathological diagnoses with regard to the age subgroups and time periods.
RESULTS: Among 7456 patients who underwent renal biopsy, 982 and 838 patients had NS and NPU, respectively. The most common diagnosis in NS was minimal change disease (MCD) (33.3%), followed by membranous nephropathy (MN) (23.6%) and lupus nephritis (LN) (12.8%); whereas the most common diagnosis in NPU was LN (27.4%), followed by immunoglobulin A nephropathy (IgAN) (21.4%) and diabetic nephropathy (DN) (9.3%). In the NS group, MCD was the most common diagnosis in young adults while MN was the leading cause in the elderly. On the other hand, LN was the most common pathology in the NPU group until the age of 60. Over the past three decades, there was a trend of decrease in the proportion of IgAN in both NS and NPU group, while a combined pathology of hypertensive nephrosclerosis and diabetic nephropathy (HTNS and DN) increased significantly.
CONCLUSIONS: The causes of NS and NPU in Chinese adults were different and may represent two distinct pathological identities. The spectrum of renal histopathology among these two groups changed significantly over time.
© 2017 Asian Pacific Society of Nephrology.

Entities:  

Keywords:  glomerulonephritis; nephrotic syndrome; nephrotic-range proteinuria

Mesh:

Year:  2018        PMID: 28425160     DOI: 10.1111/nep.13061

Source DB:  PubMed          Journal:  Nephrology (Carlton)        ISSN: 1320-5358            Impact factor:   2.506


  6 in total

1.  Clinical and pathological analysis of renal biopsies of elderly patients in Northeast China: a single-center study.

Authors:  Ping Nie; Yan Lou; Yali Wang; Xue Bai; Li Zhang; Shan Jiang; Bing Li; Ping Luo
Journal:  Ren Fail       Date:  2021-12       Impact factor: 2.606

2.  Screening and Analysis of Key Genes in miRNA-mRNA Regulatory Network of Membranous Nephropathy.

Authors:  Yawei Hou; Yameng Li; Yichuan Wang; Wenpu Li; Zhenwei Xiao
Journal:  J Healthc Eng       Date:  2021-11-16       Impact factor: 2.682

3.  Poor perception of chronic kidney diseases and its influencing factors among diabetics patients.

Authors:  Shamsul Azhar Shah; Haryati Anuar; Abdul Halim Abdul Gafor; Nik Nairan Abdullah
Journal:  Sci Rep       Date:  2022-04-05       Impact factor: 4.379

4.  The difference between patients with nephrotic syndrome and nephrotic-range proteinuria in IgA nephropathy: a propensity score matched cohort study.

Authors:  Hongfen Li; Fanghao Wang; Junya Jia; Tiekun Yan; Youxia Liu; Shan Lin
Journal:  BMC Nephrol       Date:  2022-04-29       Impact factor: 2.585

5.  Comparison between outcomes of IgA nephropathy with nephrotic-range proteinuria and nephrotic syndrome: do podocytes play a role?

Authors:  Yizhen Chen; Aicheng Yang; Yuansheng Hou; Longhui Liu; Jiehua Lin; Xiaodan Huang; Jundu Li; Xusheng Liu; Fuhua Lu; Qizhan Lin; Haifeng Yang; Shuling Yue; Shujun Jiang; Lixin Wang; Chuan Zou
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

6.  Development and validation of a discrimination model between primary PLA2R-negative membranous nephropathy and minimal change disease confirmed by renal biopsy.

Authors:  Feng Wu; Yiding Zhang; Wen Cui; Yijun Dong; Yingyang Geng; Changhao Liu; Zemeng Li; Yandong Xie; Xiaojing Cai; Jin Shang; Jing Xiao; Zhanzheng Zhao
Journal:  Sci Rep       Date:  2021-09-10       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.